A rogue set of “zombie” immune cells may be driving aging and fatty liver disease by flooding tissues with inflammation.

UCLA researchers have identified a rogue population of immune cells that quietly accumulates in aging tissues and in the ...

Researchers at Toronto's Sinai Health have found that semaglutide – the active ingredient in popular weight loss drugs that ...

Liver fibrosis represents a serious worldwide health issue with a prevalence of around 5% in general populations.1 The most ...

An experimental molecule could become a new 'natural Ozempic' without the laundry list of side effects, researchers at ...

GLP-1 drugs have direct beneficial effects on the liver, independent ​of their benefits for obesity, researchers studying the ...

Scientists have identified a particular protein in the body that may influence the progression of alcohol-associated liver ...

BioVie is eyeing a $19.7 million IPO for a spinout focused on bringing a new formulation of an approved kidney failure drug to market as a potential treatment for liver disease. The plan is to offer 1 ...

March 9 (Reuters) - GSK (GSK.L), opens new tab said on Monday it ‌will receive up to $690 million from Italian pharmaceutical company Alfasigma for the worldwide rights to linerixibat, an experimental ...

Allison is experienced editor and writer with over 6 years of expertise in both digital and print media, working with city magazines, health and fitness platforms, blogs, podcasts, and small business ...

A new study suggests that even modest amounts of this carbonated beverage may be associated with higher rates of metabolic fatty liver disease. A new study, published in the Annals of Hepatology, ...

SynGenSys, a biotechnology company designing synthetic gene promoter systems to address critical bottlenecks in biopharma manufacturing and enhance cell and gene therapy development, today announced ...